TOXI 139 |
| One pathway of polycyclic aromatic hydrocarbon (PAH) activation involves the AKR catalyzed oxidation of PAH trans-dihydrodiols to yield reactive and redox-active o-quinones. Evidence for this pathway is presented in A549 cells which constitutively express AKR1A1, and AKR1C1-AKR1C3. Cells treated with PAH trans-dihydrodiols form the corresponding o-quinones as measured by LC/MS. Upon treatment with B[a]P-7,8-dihydrodiol (AKR substrate) and B[a]P-7,8-dione (AKR product), cells produce reactive-oxygen species (measured by increases in in cell fluorescence and FACS analysis using dichlorofluorescein diacetate), undergo changes in redox state (measured by increases in GSSG : GSH and NADP+ : NADPH), undergo increased single-strand-DNA breaks (measured by Comet assay coupled to the base-excision repair enzyme hOGG1), and produce 8-oxo-dGuo (measured by stable isotope dilution LC/MS). These effects were enhanced by a COMT inhibitor and were not seen with B[a]P-4,5-dihydrodiol or anti-B[a]PDE. These studies support a role for AKRs in PAH-lung carcinogenesis. Supported by P01CA092537, P30ES013508 and R01CA39504. |
|
General Papers
1:00 PM-4:45 PM, Wednesday, August 22, 2007 BCEC -- 258C, Oral
Division of Chemical Toxicology |